New insights on nitric oxide: Focus on animal models of schizophrenia
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 409, 113304
Abstract
No abstract availableKeywords
Funding Information
- CINVESTAV IPN
This publication has 99 references indexed in Scilit:
- Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophreniaSchizophrenia Research, 2020
- Neuronal and brain morphological changes in animal models of schizophreniaBehavioural Brain Research, 2016
- The role of nitric oxide donors in schizophrenia: Basic studies and clinical applicationsEuropean Journal of Pharmacology, 2015
- Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspectsFrontiers in Physiology, 2015
- The impact of environmental factors in severe psychiatric disordersFrontiers in Neuroscience, 2014
- The many faces of nitric oxide in schizophrenia. A reviewSchizophrenia Research, 2005
- Size of burden of schizophrenia and psychotic disordersEuropean Neuropsychopharmacology, 2005
- Nitric oxide as modulator of neuronal functionProgress in Neurobiology, 2001
- Methemoglobin blockade of coronary arterial soluble guanylate cyclase activation by nitroso compounds and its reversal with dithiothreitolFEBS Letters, 1979
- Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparationsProceedings of the National Academy of Sciences, 1977